[go: up one dir, main page]

NO20000822D0 - Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander - Google Patents

Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander

Info

Publication number
NO20000822D0
NO20000822D0 NO20000822A NO20000822A NO20000822D0 NO 20000822 D0 NO20000822 D0 NO 20000822D0 NO 20000822 A NO20000822 A NO 20000822A NO 20000822 A NO20000822 A NO 20000822A NO 20000822 D0 NO20000822 D0 NO 20000822D0
Authority
NO
Norway
Prior art keywords
carboxamides
oxo
substituted
receptor ligands
brain receptor
Prior art date
Application number
NO20000822A
Other languages
English (en)
Other versions
NO20000822L (no
Inventor
Pamela Albaugh
Robert W Desimone
Gang Liu
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp filed Critical Neurogen Corp
Publication of NO20000822D0 publication Critical patent/NO20000822D0/no
Publication of NO20000822L publication Critical patent/NO20000822L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20000822A 1997-08-25 2000-02-18 Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander NO20000822L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91818097A 1997-08-25 1997-08-25
PCT/US1998/017513 WO1999010347A1 (en) 1997-08-25 1998-08-24 Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands

Publications (2)

Publication Number Publication Date
NO20000822D0 true NO20000822D0 (no) 2000-02-18
NO20000822L NO20000822L (no) 2000-04-13

Family

ID=25439933

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000822A NO20000822L (no) 1997-08-25 2000-02-18 Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander

Country Status (24)

Country Link
EP (1) EP1007526A1 (no)
JP (1) JP2001514181A (no)
KR (1) KR20010023313A (no)
CN (1) CN1268136A (no)
AP (1) AP2000001742A0 (no)
AU (1) AU753800B2 (no)
BG (1) BG104192A (no)
BR (1) BR9811362A (no)
CA (1) CA2301599C (no)
EG (1) EG21717A (no)
HU (1) HUP0003258A3 (no)
IL (1) IL134291A0 (no)
IS (1) IS5382A (no)
LV (1) LV12539B (no)
NO (1) NO20000822L (no)
NZ (1) NZ502548A (no)
OA (1) OA11293A (no)
PE (1) PE130999A1 (no)
PL (1) PL338783A1 (no)
SI (1) SI20270A (no)
SK (1) SK2162000A3 (no)
TW (1) TW574221B (no)
WO (1) WO1999010347A1 (no)
YU (1) YU10500A (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1177177B1 (en) * 1999-05-06 2005-02-23 Neurogen Corporation Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands
AU5289600A (en) * 1999-05-25 2000-12-12 Neurogen Corporation 4h-1,4-benzothiazine-2-carboxamides and their use as gaba brain receptor ligands
US6562822B2 (en) 2000-07-12 2003-05-13 Pharmacia & Upjohn Company Heterocyle carboxamides as antiviral agents
US6559145B2 (en) 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
US6730682B2 (en) 2000-07-12 2004-05-04 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
HUP0302367A2 (hu) 2000-10-12 2003-11-28 Merck & Co., Inc. HIV Integráz inhibitorokként hasznos aza- és poliazanaftalenil-karboxamidok, ezeket tartalmazó gyógyszerkészítmények
WO2002030426A1 (en) 2000-10-12 2002-04-18 Merck & Co., Inc. Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
US6841558B2 (en) 2000-10-12 2005-01-11 Merck & Co., Inc. Aza-and polyaza-naphthalenyl carboxamides useful as HIV intergrase inhibitors
US20020151591A1 (en) * 2000-10-17 2002-10-17 Anabella Villalobos Combination use of acetylcholinesterase inhibitors and GABAa inverse agonists for the treatment of cognitive disorders
NZ527397A (en) * 2001-03-01 2005-05-27 Pfizer Prod Inc Use of GABAA inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators, or vitamin E for the treatment of cognitive disorders
AR036256A1 (es) 2001-08-17 2004-08-25 Merck & Co Inc Sal sodica de un inhibidor de integrasa del vih, procesos para su preparacion, composiciones farmaceuticas que lo contienen y su uso para la manufactura de un medicamento
CA2472372C (en) 2002-01-17 2010-08-17 Melissa Egbertson Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors
JP4494020B2 (ja) 2002-03-15 2010-06-30 メルク・シャープ・エンド・ドーム・コーポレイション Ｈｉｖインテグラーゼ阻害剤として有用なｎ−（置換ベンジル）−８−ヒドロキシ−１，６−ナフチリジン−７−カルボキサミド
WO2004106336A1 (en) * 2003-05-27 2004-12-09 Pfizer Products Inc. Process for the preparation and purification of 1,5-naphthyridine-3-carboxyamides
WO2004106334A2 (en) * 2003-05-28 2004-12-09 Pfizer Products Inc. Process for the preparation of 1,5-naphthyridine-3-carboxy amides by direct ester amidation
EP2540722B1 (en) * 2006-10-16 2016-06-08 Bionomics Limited Novel anxiolytic compounds
EP2083811B1 (en) * 2006-11-22 2016-10-26 Clinical Research Associates, LLC Methods of treating down's syndrome, fragile x syndrome and autism

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR204813A1 (es) * 1972-05-08 1976-03-05 Yamanouchi Pharma Co Ltd Proceso para la preparacion de derivados de ampilicina
GB1433774A (en) * 1973-02-26 1976-04-28 Allen & Hanburys Ltd Heterocyclic compounds apparatus for conveying articles
US4374138A (en) * 1981-11-13 1983-02-15 Warner-Lambert Company Antibacterial amide compounds, compositions, and methods of use
DD295360A5 (de) * 1987-07-03 1991-10-31 Akad Wissenschaften Verfahren zur Herstellung von aktivierten Carbonsäureestern
DD279887A1 (de) * 1987-07-03 1990-06-20 Inst Pharmakologische Forschun Verfahren zur herstellung von d-alpha-(4(1h)-1,5-naphthyridon-3-carboxamido)-benzylpenicillin und anderen beta-lactamantibiotika
DD279875A1 (de) * 1987-07-03 1990-06-20 Inst Pharmakologische Forschun Verfahren zur herstellung von aktivierten carbonsaeureestern
JPS6461461A (en) * 1987-09-01 1989-03-08 Otsuka Pharma Co Ltd Benzohetero ring derivative

Also Published As

Publication number Publication date
AU9117398A (en) 1999-03-16
NO20000822L (no) 2000-04-13
BG104192A (en) 2001-05-31
CN1268136A (zh) 2000-09-27
AU753800B2 (en) 2002-10-31
KR20010023313A (ko) 2001-03-26
TW574221B (en) 2004-02-01
IL134291A0 (en) 2001-04-30
PL338783A1 (en) 2000-11-20
BR9811362A (pt) 2000-08-22
SK2162000A3 (en) 2001-03-12
EP1007526A1 (en) 2000-06-14
CA2301599C (en) 2003-03-25
HUP0003258A2 (en) 2001-03-28
JP2001514181A (ja) 2001-09-11
YU10500A (sh) 2002-10-18
CA2301599A1 (en) 1999-03-04
AP2000001742A0 (en) 2000-02-24
WO1999010347A1 (en) 1999-03-04
LV12539A (en) 2000-10-20
EG21717A (en) 2002-02-27
PE130999A1 (es) 1999-12-16
HUP0003258A3 (en) 2001-05-28
IS5382A (is) 2000-02-22
OA11293A (en) 2002-11-19
LV12539B (en) 2001-01-20
NZ502548A (en) 2002-06-28
SI20270A (sl) 2000-12-31

Similar Documents

Publication Publication Date Title
PT860428E (pt) Compostos pirimidiona
NO994877D0 (no) Kalsilytiske forbindelser
NO20000822D0 (no) Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander
MX225999B (es) Polimorfo antifungico cristalino.
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
ID20323A (id) Senyawa-senyawa triazinilaminostilbena
AU2217200A (en) 2-amino-9-alkylpurines: gaba brain receptor ligands
NO994900D0 (no) Forbindelser
BR9804301B1 (pt) compostos espirocÍclicos.
ID20093A (id) Metode untuk memproduksi polibutilena tereptalat
EE9900602A (et) Ühendid
ID22983A (id) Senyawa-senyawa fluorometoksimino
NO995007D0 (no) Forbindelser
ID24348A (id) Metode untuk penyiapan melamin
DE59808274D1 (de) Hirnspatel
DE69737634D1 (de) Insektizide oxadiazinverbindungen
AU2653499A (en) Oxo-dipyridoimidazole-carboxamides: gaba brain receptor ligands
ZA987957B (en) Substituted 4-oxo-napthyridine-3-carboxamides: gaba brain receptor ligands.
LV11827A (lv) Celamkranu celtspejas ierobezotajs
IT1297612B1 (it) Imbracatura per ciclisti
UA2297S (uk) Колодка для спеціального взуття
SE9701220D0 (sv) New compounds
SE9702378D0 (sv) New compounds
SE9704839D0 (sv) New compounds
SE9704837D0 (sv) New compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application